Canada markets closed

Ekso Bionics Holdings, Inc. (EKSO)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
1.3200+0.0200 (+1.54%)
At close: 04:00PM EDT
1.3600 +0.04 (+3.03%)
After hours: 04:40PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 23.63M
Enterprise Value 21.67M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)1.08
Price/Book (mrq)1.68
Enterprise Value/Revenue 1.21
Enterprise Value/EBITDA 0.46

Trading Information

Stock Price History

Beta (5Y Monthly) 1.64
52-Week Change 3-11.86%
S&P500 52-Week Change 328.04%
52 Week High 33.1290
52 Week Low 30.6200
50-Day Moving Average 31.3497
200-Day Moving Average 31.4120

Share Statistics

Avg Vol (3 month) 3135.55k
Avg Vol (10 day) 348.72k
Shares Outstanding 518.17M
Implied Shares Outstanding 618.17M
Float 817.58M
% Held by Insiders 19.21%
% Held by Institutions 19.96%
Shares Short (Apr 30, 2024) 4222.27k
Short Ratio (Apr 30, 2024) 42.23
Short % of Float (Apr 30, 2024) 41.26%
Short % of Shares Outstanding (Apr 30, 2024) 41.22%
Shares Short (prior month Mar 28, 2024) 4134.27k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Mar 25, 2020
Ex-Dividend Date 4N/A
Last Split Factor 21:15
Last Split Date 3Mar 25, 2020

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin -79.48%
Operating Margin (ttm)-86.69%

Management Effectiveness

Return on Assets (ttm)-26.34%
Return on Equity (ttm)-80.59%

Income Statement

Revenue (ttm)17.91M
Revenue Per Share (ttm)1.20
Quarterly Revenue Growth (yoy)-8.90%
Gross Profit (ttm)N/A
EBITDA -12.23M
Net Income Avi to Common (ttm)-14.24M
Diluted EPS (ttm)-0.9800
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)8.8M
Total Cash Per Share (mrq)0.48
Total Debt (mrq)6.84M
Total Debt/Equity (mrq)48.69%
Current Ratio (mrq)2.81
Book Value Per Share (mrq)0.78

Cash Flow Statement

Operating Cash Flow (ttm)-11.31M
Levered Free Cash Flow (ttm)-6.44M